substance p has been researched along with Coronary Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chronos, NA; Coussement, PK; Cui, J; De Leon, H; King, SB; Li, J; Robinson, KA; Ueno, T | 1 |
| Ardell, JL; Hua, F; Reifsteck, A; Ricketts, BA; Williams, CA | 1 |
| Boon, NA; Ludlam, CA; Newby, DE; Robinson, SD | 2 |
| De Bruyne, B; Kearney, MT; MacCarthy, PA; Melikian, N; Shah, AM; Thomas, MR | 1 |
| Barbir, M; Bustami, M; Kushwaha, SS; Lythall, DA; Mitchell, AG; Yacoub, MH | 1 |
| Crake, T; Davies, GJ; Katsimaglis, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Hirooka, Y; Kuroiwa-Matsumoto, M; Shimokawa, H; Tagawa, H; Tagawa, T; Takeshita, A | 1 |
| Crake, T; Davies, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Collins, P; Ghatei, MA; McNeill, JG; Webb, CM | 1 |
| Akita, H; Fukuzaki, H; Yatani, A; Yokoyama, M | 1 |
1 trial(s) available for substance p and Coronary Disease
| Article | Year |
|---|---|
17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease.
Topics: Arteries; Blood Pressure; Coronary Circulation; Coronary Disease; Endothelin-1; Estradiol; Female; Heart Rate; Humans; Isosorbide Dinitrate; Middle Aged; Nitric Oxide; Papaverine; Postmenopause; Substance P; Vasodilator Agents; Women's Health | 2000 |
10 other study(ies) available for substance p and Coronary Disease
| Article | Year |
|---|---|
Vasomotor function of pig coronary arteries after chronic coronary occlusion.
Topics: Animals; Coronary Disease; Coronary Vessels; NG-Nitroarginine Methyl Ester; Radiography; Substance P; Swine; Vasoconstriction; Vasomotor System | 2003 |
Myocardial ischemia induces the release of substance P from cardiac afferent neurons in rat thoracic spinal cord.
Topics: Animals; Coronary Disease; Exudates and Transudates; Female; Heart; Male; Myocardial Ischemia; Neurons, Afferent; Nociceptors; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P; Thoracic Vertebrae | 2004 |
Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease.
Topics: Aged; Coronary Disease; Female; Fibrinolysis; Gene Deletion; Genotype; Humans; Male; Middle Aged; Nitroprusside; Polymorphism, Genetic; Substance P; Tissue Plasminogen Activator | 2006 |
Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease.
Topics: Analysis of Variance; Biomarkers; Cohort Studies; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Probability; Prospective Studies; Severity of Illness Index; Substance P; Survival Analysis; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve.
Topics: Coronary Circulation; Coronary Disease; Endothelium, Vascular; Female; Humans; Male; Microcirculation; Middle Aged; Neurotransmitter Agents; Risk Assessment; Substance P; Thermodilution | 2007 |
Coronary endothelial function in cardiac transplant recipients with accelerated coronary disease.
Topics: Adult; Blood Pressure; Coronary Angiography; Coronary Disease; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Follow-Up Studies; Heart Rate; Heart Transplantation; Humans; Isosorbide Dinitrate; Male; Middle Aged; Substance P; Vasodilation | 1994 |
Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P.
Topics: Analysis of Variance; Arginine; Coronary Angiography; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Female; Humans; Isomerism; Male; Middle Aged; Nitroglycerin; Substance P; Vasodilator Agents | 1999 |
Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease.
Topics: Acetylcholine; Aged; Coronary Disease; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Endothelium, Vascular; Forearm; Humans; Lipids; Middle Aged; Nitric Oxide; Regional Blood Flow; Substance P; Vasodilation | 1999 |
Evidence of partially preserved endothelial dilator function in diseased coronary arteries.
Topics: Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; Substance P; Vasodilation; Vasodilator Agents | 1999 |
Endothelium-dependent vasodilating effect of substance P during flow-reducing coronary stenosis in the dog.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Infusions, Intra-Arterial; Male; Nitroglycerin; Substance P; Vasodilation | 1990 |